MONTREAL - Lumiera Health Inc. (TSXV: NHP) (the 'Company' or 'Lumiera '), a company specializing in the development and commercialization of evidence-based botanical products, is pleased to announce that it has signed an agreement with Vancouver based Ecotrend Ecologics ('Ecotrend') for the national distribution of Bazzzics, a natural health product line made with a proprietary blend of plant-based extracts that have demonstrated efficacy for sleep and anxiety disorders. Founded in 1986 by John Harrison, Ecotrend is a much respected international distributor with over 50 dedicated professionals, representing high quality products and servicing natural health stores and alternative healthcare practitioners across Canada. Lumiera Health CEO Mr. Carlos Ponce states, 'We are very pleased to be working with such an established player in the Natural Health industry. With over 2500 retail and 2500 professional accounts, I look forward to rapidly increasing the number of stores selling Bazzzics so more Canadians will have greater access to better sleep'.
About Lumiera Health Inc.
Lumiera specializes in the development and commercialization of evidence-based botanical products for the healthcare industry. The Company sells both oral and topical botanical agents to help manage unmet medical needs through its Holizen Laboratories division. Lumiera is also developing and commercializing a unique portfolio of products acting on the endocannabinoid system and providing innovative solutions for chronic pain and inflammation. The Company is a pioneer in the health and pain management innovation space and the Lumiera brand is rooted in the core brand values of science, nature and compassion. Passionate about making people feel better, we deliver trustworthy and scientifically proven solutions that work with the body's own system.
Forward-looking information Certain statements contained in this press release constitute 'forward-looking information' as such term is defined in applicable Canadian securities legislation. The words 'may', 'would', 'could', 'should', 'potential', 'will', 'seek', 'intend', 'plan', 'anticipate', 'believe', 'estimate', 'expect' and similar expressions indicate such 'forward-looking information' as they relate to Lumiera. All statements other than statements of historical fact may be forward-looking information. Such statements reflect Lumiera' current views and intentions with respect to future events, and current information available to Lumiera, and are subject to certain risks, uncertainties and assumptions. Such risks and uncertainties include, among others, the risk factors included in Lumiera' annual management's discussion and analysis for the year ended November 30, 2020, which is available under the issuer's SEDAR profile at www.sedar.com. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. Should any factor affect Lumiera in an unexpected manner, or should assumptions underlying the forwardlooking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, Lumiera does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and Lumiera undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.
Lumiera Health Inc.
Interim Chief Financial Officer
(C) 2021 Electronic News Publishing, source ENP Newswire